{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:38:43Z","timestamp":1783042723578,"version":"3.54.6"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>A 29-year-old female patient diagnosed with primary aldosteronism (PA) in 2004 underwent complete adrenalectomy for left aldosterone-producing adenoma (APA) confirmed by hematoxylin and eosin (HE) and CYP11B2 staining. Her hypokalemia was corrected, and her blood pressure (BP) normalized and maintained without medication for 10 years. In 2014, her BP became elevated again, and a recurrence of PA with an adenoma on the right adrenal gland was discovered by computed tomography scan. She underwent partial right adrenalectomy in 2018 due to unsatisfactory BP control with medication and gradually enlarging adenoma. The resected adrenal tissue contained a CYP11B2 staining positive APA. Her BP was then controlled by two drugs. Sanger sequencing of DNA extracted from tissue slices revealed that both left and right adenomas carried the same aldosterone-driver <jats:italic>KCNJ5<\/jats:italic> gene mutation, but with different nucleotide changes. We suggest that patients who undergo adrenalectomy for APA should be followed up for life.<\/jats:p>","DOI":"10.3389\/fendo.2021.728595","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:45:56Z","timestamp":1632530756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Recurrence of Primary Aldosteronism 10 Years After Left Adrenalectomy for Aldosterone-Producing Adenoma: A Case Report"],"prefix":"10.3389","volume":"12","author":[{"given":"Linghui","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism: An International Consensus on Outcome Measures and Analysis of Remission Rates in an International Cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-009-0498-4","article-title":"Long-Term Effects of Surgical Correction of Adrenal Hyperplasia and Adenoma Causing Primary Aldosteronism","volume":"395","author":"Hennings","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-014-1269-4","article-title":"Outcome of Surgical Treatment of Primary Aldosteronism","volume":"400","author":"Citton","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785","article-title":"K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic Mutations in ATP1A1 and ATP2B3 Lead to Aldosterone-Producing Adenomas and Secondary Hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2716","article-title":"Somatic Mutations in ATP1A1 and CACNA1D Underlie a Common Subtype of Adrenal Hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695","article-title":"Somatic and Germline CACNA1D Calcium Channel Mutations in Aldosterone-Producing Adenomas and Primary Aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315","article-title":"Recurrent Gain of Function Mutation in Calcium Channel CACNA1H Causes Early-Onset Hypertension With Primary Aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 Chloride Channel Mutations in Familial Hyperaldosteronism Type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0053-8","article-title":"A Gain-of-Function Mutation in the CLCN2 Chloride Channel Gene Causes Primary Aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/srep19546","article-title":"Activating Mutations in CTNNB1 in Aldosterone Producing Adenomas","volume":"6","author":"Akerstrom","year":"2016","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/biomedicines9040409","article-title":"Update on Genetics of Primary Aldosteronism","volume":"9","author":"Itcho","year":"2021","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0","article-title":"A Chimaeric 11 Beta-Hydroxylase\/Aldosterone Synthase Gene Causes Glucocorticoid-Remediable Aldosteronism and Human Hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2986","article-title":"Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/eje.0.1510073","article-title":"Postoperative Differentiation Between Unilateral Adrenal Adenoma and Bilateral Adrenal Hyperplasia in Primary Aldosteronism by Mrna Expression of the Gene CYP11B2","volume":"151","author":"Enberg","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002520","article-title":"Subtype Diagnosis, Treatment, Complications and Outcomes of Primary Aldosteronism and Future Direction of Research: A Position Statement and Consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International Histopathology Consensus for Unilateral Primary Aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.amjsurg.2020.12.003","article-title":"Trends in Blood Pressure-Related Outcomes After Adrenalectomy in Patients With Primary Aldosteronism: A Systematic Review","volume":"222","author":"Suurd","year":"2021","journal-title":"Am J Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jfma.2018.01.006","article-title":"Targeted Treatment of Primary Aldosteronism - the Consensus of Taiwan Society of Aldosteronism","volume":"118","author":"Huang","year":"2019","journal-title":"J Formos Med Assoc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.728595\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:46:01Z","timestamp":1632530761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.728595\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":26,"alternative-id":["10.3389\/fendo.2021.728595"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.728595","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"728595"}}